GeminIQ Website Logo

Viewing AFJK free

Start free trial

Subscribe for full history, 50+ metrics, screener, watchlist...

Aimei Health Technology Co., Ltd.

AFJK

Companies in Blank Checks

EVACANSCALUBCCIIDMIIBCSS

Aimei Health Technology Co., Ltd. (AFJK) — SEC Financial Statements & Analysis

Aimei Health Technology Co., Ltd. (AFJK) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash
0000000001
Assets Current
Assets Current
0000000001
Prepaid Expense Current
0-0000000-
Other Receivables
--------0-
Assets Held In Trust Noncurrent
12124545447473727170
Assets
12124545447473727170
Liabilities And Stockhold…
Accrued Liabilities Current
0000000000
Liabilities Current
Liabilities Current
4332210000
Other Short Term Borrowings
222110----
Other Liabilities Current
11110000--
Redeemable Noncontrolling…
Deferred Compensation Liability Classified Noncurr…
1111111111
Liabilities
4433221111
Temporary Equity Carrying Amount Attributable To P…
12124545447473727170
Common Stock Value
0000000000
Stockholders Equity
Stockholders Equity
-4-4-3-3-2-1-1-1-0-0
Retained Earnings Accumulated Deficit
-4-4-3-3-2-1-1-1-0-0
Temporary Equity Par Or Stated Value Per Share
---------0
Temporary Equity Shares Authorized
---------500
Liabilities And Stockholders Equity
12124545447473727170
Temporary Equity Shares Issued
8888877777
Temporary Equity Shares Outstanding
8888877777
Temporary Equity Redemption Price Per Share
11.811.6311.3711.1410.9110.6910.5310.3910.2610.13
Common Stock Par Or Stated Value Per Share
0000000000
Common Stock Shares Authorized
500500500500500500500500500500
Common Stock Shares Issued
2222222222
Shares Outstanding
4444266666
Shares Subject To Mandatory Redemption Settlement …
1144477777

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-60.36%-----------
20251.09%1.09%2.45%0.36%1.07%2.05%182.03%537.64%360.65%-3.45%-38.37%-
20240.19%0.61%0.78%0.38%0.77%1.15%-0.39%0.37%1.02%-0.06%1.39%1.39%
2023---------0.79%1.18%2.73%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.01
0.00
0.01
0.02
0.00
0.04
0.54
1.84
6.13
23.38
Quick Ratio
0.01
0.00
0.00
0.00
0.00
0.03
0.45
1.42
5.28
23.38
Working Capital
-3.50M
-3.37M
-2.75M
-2.17M
-1.68M
-786.61K
-106.89K
93.13K
402.24K
555.88K
Leverage & Debt
Debt to Equity
-1.00
-1.00
-1.01
-1.02
-1.00
-1.02
-1.16
-1.34
-2.67
-5.33
Debt Ratio
0.34
0.34
0.08
0.07
0.05
0.02
0.01
0.01
0.01
0.01
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Per Share Metrics
Diluted EPS TTM
-
0.26
0.35
0.45
0.38
0.37
0.31
-
-
-
Free Cash Flow Per Share TTM
-0.30
-0.09
-0.13
-0.12
-0.06
-0.10
-0.07
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Growth Metrics
Net Income Growth (1Y)
-53.54%
-58.48%
-33.32%
-
-
-
-
-
-
-
EPS Growth (1Y)
12.71%
-29.21%
15.15%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
56.58
244.46
32.18
24.79
28.62
28.93
34.30
-
-
-
P/B
-12.43
-63.83
-13.15
-15.58
-23.95
-50.00
-90.74
-119.65
-246.02
-
Market Cap
52.09M
259.07M
45.23M
44.55M
56.72M
73.83M
72.31M
71.42M
70.79M
-
Enterprise Value
52.07M
259.07M
45.23M
44.55M
56.71M
73.80M
72.21M
71.26M
70.38M
-
Calculated Values
Free Cash Flow TTM
-639.71K
-363.35K
-515.25K
-473.09K
-303.57K
-672.29K
-477.16K
-
-
-
Net Debt
-18.52K
-2.93K
-2.98K
-2.14K
-7.35K
-28.21K
-103.56K
-157.51K
-413.75K
-580.72K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-02-11Sale
Owner: Mizuho, Securities Usa Ll…
Title: -
Shares: 150,000
Price/Share: $10.86
Value: $1,629,000.00
Shares Owned: 550,387
Relationship: TenPercentOwner
Ownership: Direct
2023-12-01Purchase
Owner: Aimei, Investment Ltd
Title: -
Shares: 332,000
Price/Share: $10.00
Value: $3,320,000.00
Shares Owned: 1,905,000
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart
2026-03-31
20.78%
Inst. Shares: 841,011
Shares Outstanding: 4,047,369
2025-12-31
19.35%
Inst. Shares: 783,112
Shares Outstanding: 4,047,369
2025-09-30
92.55%
Inst. Shares: 3,697,866
Shares Outstanding: 3,995,733
2025-06-30
92.94%
Inst. Shares: 3,713,460
Shares Outstanding: 3,995,733
2025-03-31
70.61%
Inst. Shares: 3,641,752
Shares Outstanding: 5,157,440

Research Faster.
Invest Smarter.

Start 7-day free trial

Aimei Health Technology Co., Ltd. (AFJK) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.